ARANESP -(HSA-FREE)
ARANESP -(HSA-FREE)
Discontinued
DIN Number
02246357
Drug Class
Human
Market Date
Aug 20, 2002
Company
HC
Amgen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02246357
AIG Number0148081005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
B03XA02 DARBEPOETIN ALFA
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
,
Subcutaneous
AHFS Classification20:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DARBEPOETIN ALFAActive
Strength: 100 MCG / ML
Monograph: DARBEPOETIN ALFA